Home/Filings/4/0002001011-25-000068
4//SEC Filing

KOZARICH JOHN W 4

Accession 0002001011-25-000068

CIK 0000886163other

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 5:47 PM ET

Size

9.0 KB

Accession

0002001011-25-000068

Insider Transaction Report

Form 4
Period: 2025-09-02
Transactions
  • Sale

    Common Stock

    2025-09-02$161.51/sh267$43,12445,722 total
  • Sale

    Common Stock

    2025-09-02$162.52/sh115$18,69045,607 total
  • Sale

    Common Stock

    2025-09-02$164.25/sh85$13,96145,522 total
Footnotes (4)
  • [F1]The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.
  • [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $161.0300 to $162.0200. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $162.3600 to $162.6000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $163.9900 to $164.5000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeother

Related Parties

1
  • filerCIK 0001223000

Filing Metadata

Form type
4
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 5:47 PM ET
Size
9.0 KB